Although heart transplantation is a final therapeutic option in pediatric patients with dilated cardiomyopathy (DCMP), the shortage of pediatric heart donors is a major obstacle. In adults with DCMP characterized by cardiac dyssynchrony, cardiac resynchronization therapy (CRT) is known to be an effective treatment option. However, there is a lack of evidence on the effectiveness of CRT in infants with DCMP. Several studies have reported improvement in hemodynamics and cardiac performance following CRT in infants with DCMP. Here, we report CRT in an infant with DCMP during extracorporeal membrane oxygenation with 5 months of follow-up.
A 5-month-old girl who was diagnosed with dilated cardiomyopathy (DCMP) at 3 months of age was admitted to our hospital with excessive sweating, poor oral intake, and oliguria. On admission, the echocardiogram showed a markedly enlarged left ventricular (LV) end diastolic dimension of 47 mm, decreased LV ejection fraction of 15%, and more than moderate mitral regurgitation (MR) ( Table 1 ). An electrocardiogram revealed a prolonged QRS duration of 130 ms (Table 1) . Despite maximum medical treatment including infusion of a high dosage of inotropes and vasodilators in the intensive care unit, decreased urine output and severe lactic acidosis persisted, and the blood level of brain natriuretic peptide (BNP) remained high at 9,669 pg/mL (Table 1) .
Emergency extracorporeal membrane oxygenation (ECMO)
was initiated through an open cervical approach, and the patient was listed as a candidate for heart transplantation.
Considering the extreme shortage of heart donors in young children, we attempted to wean the patient off ECMO and succeeded after 8 days of support. While awaiting heart transplantation, the patient's condition rapidly deteriorated and she required repeated ECMO support 20 days after being weaned off ECMO. Unfortunately, ischemic insult to the brain, kidney, and bowel was evident, and significant sequelae were expected to remain. Therefore, the heart transplantation was aborted, and a decision was made to offer cardiac resynchronization therapy (CRT) as another option. Measured by the M-mode. contraction. Septal-to-posterior wall motion delay was 236 ms by the M-mode (Table 1) . Tissue synchronization imaging showed intraventricular dyssynchrony (Fig. 1) . Thus, we decided to perform CRT during ECMO support. Tissue synchronization imaging showed intraventricular synchrony ( Fig. 1) . Chest radiography demonstrated a reduced cardiac shadow (Fig. 2) . Although her cardiac function has been nearly normalized, the patient still requires intensive care because of multiple organ dysfunction related to ischemic insult during the 2nd ECMO.
DISCUSSION
It is generally believed that CRT is the optimal treatment for adults with severe LV dysfunction and cardiac dyssynchrony [1, 2] . The indication of CRT in adults with heart failure is expanding with the accumulation of knowledge obtained from well-designed studies [3] . CRT implantation is recommended in cases that meet the following criteria: (1) patients who have a LV ejection fraction less than or equal to 35%; (2) sinus rhythm, left bundle branch block with QRS duration equal to or longer than 150 ms; and (3) New York
Heart Association class II, III, or IV symptoms. In contrast, there have been no definite guidelines for CRT in pediatric patients because of the lack of experience and the heterogeneous etiology of heart failure. Although several large cohort studies regarding CRT in pediatric patients have been reported [4, 5] , most reports are case series that focus on heart failure after surgery for congenital heart diseases, right ventricular pacing-induced cardiomyopathy, and heart failure in patients with a functional single ventricle. In our case, DCMP is a rare disease entity for CRT in the pediatric population, and it is extremely rare that CRT is performed during ECMO in infants despite several reports for adults [6, 7] . It is challenging to perform CRT in a small infant during ECMO.
Since the lead must be epicardially implanted in the operating theater in small infants, it could be difficult to safely implant the LV lead in an appropriate site and to avoid major bleeding complications during anticoagulation. To achieve these objectives, we decided to use two separate incisions. The LV lead was implanted through the left anterolateral thoracotomy, which allowed better exposure and less bleeding compared with the full sternotomy, and a subxiphoid incision was made Had we considered CRT to be the primary option instead of heart transplantation, this baby would have been happier.
Even though there is currently no definite guideline for CRT in pediatric patients, CRT must be strongly considered a treatment option in infants having heart failure with ventricular dyssynchrony.
According to our experience, CRT could be safely performed in small infants during ECMO, and the outcome of CRT might be promising in selected infants with end-stage heart failure.
